Craig Coleman
Professor/Pharmacy Practice
Storrs Mansfield
Are you Craig Coleman?
How to update your information.
Scholarly Contributions
620 Scholarly Contributions
Impact of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on renal and mortality outcomes in people with Type 2 diabetes and proteinuria.
2020
Research Type: Journal Article
Treatment patterns, glycemic control & bodyweight with canagliflozin 300 mg versus GLP1RAs in Type II diabetes patients.
2019
Research Type: Journal Article
The impact of non-medical switching among ambulatory patients: an updated systematic literature review.
2019
Research Type: Journal Article
Clinical and Economic Outcomes in Low-risk Pulmonary Embolism Patients Treated with Rivaroxaban versus Standard of Care.
2019
Research Type: Journal Article
Influence of Polypharmacy on the Effectiveness and Safety of Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation.
2019
Research Type: Journal Article
Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults.
2019
Research Type: Journal Article
The value of sPESI for risk stratification in patients with pulmonary embolism.
2019
Research Type: Journal Article
Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation.
2019
Research Type: Journal Article
Comparative risk of major bleeding with rivaroxaban and warfarin: Population-based cohort study of unprovoked venous thromboembolism.
2019
Research Type: Journal Article
Healthcare costs of stroke and major bleeding in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants.
2019
Research Type: Journal Article
Effectiveness and safety of rivaroxaban and warfarin for prevention of major adverse cardiovascular or limb events in patients with non-valvular atrial fibrillation and type 2 diabetes.
2019
Research Type: Journal Article
Impact of Prolonged Anticoagulation with Rivaroxaban on Provoked Venous Thromboembolism Recurrence: IMPROVE-VTE.
2019
Research Type: Journal Article
Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and coronary or peripheral artery disease.
2019
Research Type: Journal Article
Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoing Hemodialysis.
2019
Research Type: Journal Article
Proportion of US Hospitalized Medically Ill Patients Who May Qualify for Extended Thromboprophylaxis.
2019
Research Type: Journal Article
Rivaroxaban Versus Warfarin and Renal Outcomes in Non-valvular Atrial Fibrillation Patients with Diabetes.
2019
Research Type: Journal Article
Cost and inpatient burden of peripheral artery disease: Findings from the National Inpatient Sample.
2019
Research Type: Journal Article
AHRQ series on improving translation of evidence: linking evidence reports and performance measures to help learning health systems use new information for improvement
2019
Research Type: Journal Article
Safety and effectiveness of oral factor Xa inhibitors versus warfarin in nonvalvular atrial fibrillation patients at high-risk for falls.
2019
Research Type: Journal Article